We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.81%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81B
AUM Growth
+$6.66B
Cap. Flow
+$1.82B
Cap. Flow %
2.24%
Top 10 Hldgs %
22.31%
Holding
3,027
New
17
Increased
2,329
Reduced
595
Closed
62

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$164M
2
MSFT icon
Microsoft
MSFT
+$157M
3
AMZN icon
Amazon
AMZN
+$75.7M
4
TSLA icon
Tesla
TSLA
+$50M
5
GEHC icon
GE HealthCare
GEHC
+$45.2M

Sector Composition

Rank Sector Weight
1 Technology 25.37%
2 Healthcare 13.58%
3 Financials 12.66%
4 Consumer Discretionary 10.75%
5 Industrials 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RUSHB icon
2351
Rush Enterprises Class B
RUSHB
$6.14B
$611K ﹤0.01%
15,311
-216
-1% -$8.36K
FF icon
2352
Future Fuel
FF
$223M
$609K ﹤0.01%
82,492
+3,806
+5% +$32.7K
GEF.B icon
2353
Greif Class B
GEF.B
$4.21B
$609K ﹤0.01%
7,965
-111
-1% -$8.68K
GEVO icon
2354
Gevo
GEVO
$382M
$609K ﹤0.01%
395,286
+28,938
+8% +$54.8K
MLR icon
2355
Miller Industries
MLR
$619M
$609K ﹤0.01%
17,236
+617
+4% +$18.3K
ORGN
2356
DELISTED
Origin Materials
ORGN
$609K ﹤0.01%
4,756
+40
+0.8% +$5.91K
VITL icon
2357
Vital Farms
VITL
$525M
$608K ﹤0.01%
39,767
+1,608
+4% +$25.5K
SLGC
2358
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$608K ﹤0.01%
238,285
+14,370
+6% +$41.2K
QVCGA
2359
DELISTED
QVC Group Inc Series A
QVCGA
$606K ﹤0.01%
12,274
+501
+4% +$45K
TRC icon
2360
Tejon Ranch
TRC
$451M
$605K ﹤0.01%
33,120
+541
+2% +$10.4K
NPKI
2361
NPK International
NPKI
$1.14B
$603K ﹤0.01%
156,611
+5,132
+3% +$22.5K
MDXG icon
2362
MiMedx Group
MDXG
$633M
$602K ﹤0.01%
176,605
+5,898
+3% +$22.8K
SHCR
2363
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$602K ﹤0.01%
423,654
+17,898
+4% +$40.6K
EGY icon
2364
Vaalco Energy
EGY
$594M
$600K ﹤0.01%
132,350
+16,929
+15% +$77.4K
MVIS icon
2365
Microvision
MVIS
$78.9M
$600K ﹤0.01%
14,985
+576
+4% +$21.8K
OLPX
2366
DELISTED
Olaplex Holdings
OLPX
$600K ﹤0.01%
140,487
+11,705
+9% +$62.4K
FFWM
2367
DELISTED
First Foundation Inc
FFWM
$599K ﹤0.01%
80,413
+2,757
+4% +$36.8K
ALKT icon
2368
Alkami Technology
ALKT
$2.11B
$596K ﹤0.01%
47,085
+1,991
+4% +$29.4K
ARQT icon
2369
Arcutis Biotherapeutics
ARQT
$3.18B
$596K ﹤0.01%
54,166
+789
+1% +$11.4K
EQBK icon
2370
Equity Bancshares
EQBK
$1.05B
$596K ﹤0.01%
24,441
+456
+2% +$13.4K
DHC
2371
Diversified Healthcare Trust
DHC
$2.14B
$591K ﹤0.01%
437,593
-5,727
-1% -$5.92K
DYN icon
2372
Dyne Therapeutics
DYN
$4.9B
$590K ﹤0.01%
51,180
+1,966
+4% +$25.5K
CTOS icon
2373
Custom Truck One Source
CTOS
$2.37B
$588K ﹤0.01%
86,541
+4,814
+6% +$33.4K
DAWN
2374
DELISTED
Day One Biopharmaceuticals
DAWN
$588K ﹤0.01%
43,996
+1,043
+2% +$20.4K
ONTF
2375
DELISTED
ON24
ONTF
$579K ﹤0.01%
66,128
+3,213
+5% +$28.4K

Similar funds

RhumbLine Advisers's Q1 2023 Portfolio in Review

As of Q1 2023, RhumbLine Advisers held 3,027 positions worth $81B, up 9% from $74.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 2.6%. RhumbLine Advisers opened 17 new positions and exited 62, leaving the 3,027-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q1 2023 buy was GE HealthCare: 633,417 shares worth $52M.
  • RhumbLine Advisers added most to Apple in Q1 2023, an estimated $164M increase.
  • RhumbLine Advisers's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $33M.
  • RhumbLine Advisers fully exited STORE Capital Corporation in Q1 2023, selling an estimated $26.2M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $81B portfolio in Q1 2023.
  • RhumbLine Advisers opened 17 new positions and closed 62 in Q1 2023.
  • RhumbLine Advisers's portfolio value rose 9% quarter-over-quarter to $81B.

Based on RhumbLine Advisers's 13F filing for Q1 2023, filed 11 May 2023.